Clinical Trial Update: Study of M5049 in DM and PM Participants (NEPTUNIA) [Phase 2]

View source ↗

Summary

A Phase 2 trial (NEPTUNIA) evaluating M5049 for Dermatomyositis and Polymyositis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• M5049

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Dermatomyositis, Polymyositis | Phase 2 | Status: TERMINATED